Previously, we examined the reasons why one might consider attempting to identify and remove outliers from bioassay data. From a scientific perspective, omitting any collected data is never ideal,... read more →
Outliers are among the topics which stimulate the most vigorous debate among the bioassay community. When a datapoint falls outside of the usual range observed for that metric, it... read more →
In many fields of science, researchers often face the challenge of measuring extremely small quantities. The life sciences are no exception, with experiments regularly requiring accurate and precise detections... read more →
In In Vitro vs In Vivo Potency Assays: Modern Vaccine Batch Release, we examined the pros and cons of two methods of testing vaccine potency: in vivo assays, which... read more →
The previous blogs in our collaboration with the team at RoukenBio – the Immunology CRO redefined – have focused predominantly on the biological aspects of bioassay development. Including aspects... read more →